L-Carnosine
SupplementEndogenous dipeptide supplement
Also known as: carnosine, beta-alanyl-L-histidine, Carnosine, beta-Alanyl-L-histidine, Ignotine, Karnozin, Karnozzn, L-Histidine, beta-alanyl-, Nalpha-(beta-alanyl)-L-histidine
A real evidence base, with gaps
- Regulatory standing. Sold as a supplement, not an approved drug
- Limited human data. Some human data exists, not conclusive
- Registered human trials. 53 registered studies on ClinicalTrials.gov, most advanced Phase 4
- 1 cited source. Includes primary / regulatory sources
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
L-Carnosine is a small dipeptide made of beta-alanine and histidine that occurs naturally in muscle and brain tissue. It is sold as a dietary supplement and is thought to act as a pH buffer in muscle, an antioxidant, a metal chelator, and an inhibitor of glycation reactions.
What the evidence shows
There are about 53 registered human trials and a substantial published literature, but results for outcomes such as metabolic health, cognition, and exercise performance are mixed and mostly come from small or short studies. It is not FDA-approved for any indication, and no clinical benefit is firmly established.
Key facts
Registered human trials
Live from ClinicalTrials.gov, refreshed daily.
Effect of β-alanine Supplementation on Muscle Carnosine
Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux Disease
Research on Prevention, Intervention and Mechanisms of Obesity and Its Comorbidities
Study of Gulf War Illness (GWI) by Comparing GWI and Healthy Veterans
Published literature
Live from Europe PMC. This is how much has been published, not how much is proven in humans.
The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis.
Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brush-border membrane vesicles from the rabbit. Studies with L-carnosine and glycyl-L-proline.
Non-enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent.
L-carnosine (beta-alanyl-L-histidine) and carcinine (beta-alanylhistamine) act as natural antioxidants with hydroxyl-radical-scavenging and lipid-peroxidase activities.
Sources
- PubChem compound record (CID 439224)
- Registered trials on ClinicalTrials.gov
- Published papers on Europe PMC
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.